Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
MenopausePostmenopausal Vaginal Atrophy
Interventions
DRUG

estradiol, 10 mcg

Trial Locations (57)

10016

Novo Nordisk Investigational Site, New York

15206

Novo Nordisk Investigational Site, Pittsburgh

19114

Novo Nordisk Investigational Site, Philadelphia

19611

Novo Nordisk Investigational Site, West Reading

20707

Novo Nordisk Investigational Site, Laurel

23507

Novo Nordisk Investigational Site, Norfolk

27030

Novo Nordisk Investigational Site, Mount Airy

27103

Novo Nordisk Investigational Site, Winston-Salem

28209

Novo Nordisk Investigational Site, Charlotte

29201

Novo Nordisk Investigational Site, Columbia

29401

Novo Nordisk Investigational Site, Charleston

29607

Novo Nordisk Investigational Site, Greenville

30005

Novo Nordisk Investigational Site, Alpharetta

30075

Novo Nordisk Investigational Site, Roswell

32114

Novo Nordisk Investigational Site, Daytona Beach

33324

Novo Nordisk Investigational Site, Plantation

33409

Novo Nordisk Investigational Site, West Palm Beach

33461

Novo Nordisk Investigational Site, Palm Springs

33607

Novo Nordisk Investigational Site, Tampa

33759

Novo Nordisk Investigational Site, Clearwater

36106

Novo Nordisk Investigational Site, Montgomery

36608

Novo Nordisk Investigational Site, Mobile

38120

Novo Nordisk Investigational Site, Memphis

38305

Novo Nordisk Investigational Site, Jackson

43210

Novo Nordisk Investigational Site, Columbus

44122

Novo Nordisk Investigational Site, Cleveland

47714

Novo Nordisk Investigational Site, Evansville

53209

Novo Nordisk Investigational Site, Milwaukee

61615

Novo Nordisk Investigational Site, Peoria

68510

Novo Nordisk Investigational Site, Lincoln

77030

Novo Nordisk Investigational Site, Houston

80218

Novo Nordisk Investigational Site, Denver

80220

Novo Nordisk Investigational Site, Denver

80228

Novo Nordisk Investigational Site, Lakewood

83702

Novo Nordisk Investigational Site, Boise

84070

Novo Nordisk Investigational Site, Sandy City

85050

Novo Nordisk Investigational Site, Phoenix

85712

Novo Nordisk Investigational Site, Tucson

92108

Novo Nordisk Investigational Site, San Diego

92123

Novo Nordisk Investigational Site, San Diego

94304

Novo Nordisk Investigational Site, Palo Alto

95608

Novo Nordisk Investigational Site, Carmichael

97401

Novo Nordisk Investigational Site, Eugene

97504

Novo Nordisk Investigational Site, Medford

98405

Novo Nordisk Investigational Site, Tacoma

99204

Novo Nordisk Investigational Site, Spokane

99207

Novo Nordisk Investigational Site, Spokane

06320

Novo Nordisk Investigational Site, New London

40536-0293

Novo Nordisk Investigational Site, Lexington

08648

Novo Nordisk Investigational Site, Lawrenceville

08057

Novo Nordisk Investigational Site, Moorestown

K7L 4P8

Novo Nordisk Investigational Site, Kingston

H1T 1P6

Novo Nordisk Investigational Site, Montreal

G1S 2L6

Novo Nordisk Investigational Site, Québec

M5C 1R6

Novo Nordisk Investigational Site, Toronto

M5G 1Z5

Novo Nordisk Investigational Site, Toronto

R3A 1M3

Novo Nordisk Investigational Site, Winnipeg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY